Sun Pharmaceutical has received a tentative approval to market Alfuzosin Hydrochloride Tablet in the strength of 10 mg from the United States Food and Drug Administration (USFDA).

The US Food and Drug Administration approved Simponi (golimumab), a monthly treatment for adults with moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.

Sun Pharmaceutical Industries US arm has obtained a final approval from US Food and Drug Administration (US-FDA) to market Bethanechol Chloride drug on prescription basis.

The US Food and Drug Administration (FDA) has found nine deviations in Indian drug maker Cipla’s manufacturing process during a recent inspection of the company’s Bangalore plant. The Mumbai-based company, however, said the deviations are minor ones relating to manufacturing practices.